ANDA 210824

QILU PHARM CO LTD

FDA Drug Application

Application #210824

Application Sponsors

ANDA 210824

QILU PHARM CO LTD

Marketing Status

• None (Tentative Approval): 001

Application Products

001

INJECTABLE;INTRAVENOUS, SUBCUTANEOUS

3.5MG/VIAL

0

BORTEZOMIB

BORTEZOMIB

FDA Submissions

UNKNOWN;

ORIG

1

TA

2018-11-09

STANDARD

Submissions Property Types

ORIG

1

Null

31

TE Codes

001

Prescription

AP

CDER Filings

QILU PHARM CO LTD

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210824
            [companyName] => QILU PHARM CO LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"BORTEZOMIB","activeIngredients":"BORTEZOMIB","strength":"3.5MG\/VIAL","dosageForm":"INJECTABLE;INTRAVENOUS, SUBCUTANEOUS","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/09\/2018","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-11-09
        )

)